Better Coronavirus Stock: Biogen or BioNTech?

Biotechs both big and small have rushed to develop potential treatments and vaccines for COVID-19. Biogen (NASDAQ: BIIB) is an example of a big biotech working on an experimental COVID-19 treatment, while BioNTech (NASDAQ: BNTX) is one of the small biotechs developing a coronavirus vaccine.

Investors have rewarded BioNTech's efforts a lot more than they have Biogen's so far this year. BioNTech stock is up more than 80% while Biogen is down 12% year-to-date. But which of these coronavirus-focused biotech stocks is the better pick now?

Image source: Getty Images.

Continue reading

Source Fool.com